Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Echinacea Extract GRAS Status For Binding Agent In Drugs Requested

This article was originally published in The Tan Sheet

Executive Summary

An Israeli pharmaceutical firm is seeking GRAS status for use of echinacea extract as a binding agent in certain solid-dosage form OTC and Rx drugs intended for short-term use.
Advertisement

Related Content

CTS Chemical Industries
CTS Chemical Industries
CTS Chemical Industries
Functional Food Safety Challenged By CSPI, Defended By Industry
Functional Food Safety Challenged By CSPI, Defended By Industry
Dietary Supplement, Functional Food Regulatory Harmonization Urged By GAO

Topics

Advertisement
UsernamePublicRestriction

Register

PS091659

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel